Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults withNeuromuscular Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07478172
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:11.986863+00:00
Published At
2026-03-17T00:00:00+00:00
Record Updated At
2026-03-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Neuromuscular Diseases (NMD)", "Amyotrophic Lateral Sclerosis", "Myasthenia Gravis", "Lambert-eaton Myasthenic Syndrome", "Primary Lateral Sclerosis", "Spinal Muscular Atrophy", "Charcot Marie Tooth Disease (CMT)", "Fascioscapulohumeral Muscular Dystrophy", "Inclusion Body Myositis", "Mitochondrial Myopathy", "Nemaline Myopathy", "Centronuclear Myopathy", "Postpolio Syndrome", "Pompe Disease (Late-onset)", "Chronic Inflammatory Demyelinating Polyneuropathy", "Hereditary Spastic Paraplegia", "Postural Orthostatic Tachycardia Syndrome (POTS)", "Progressive Muscular Atrophy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-17"
protocolSection.identificationModule.nctId
"NCT07478172"
protocolSection.identificationModule.officialTitle
"Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults withNeuromuscular Disease"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Neuromuscular Diseases (NMD) (protocolSection.conditionsModule.conditions)
  • Amyotrophic Lateral Sclerosis (protocolSection.conditionsModule.conditions)
  • Myasthenia Gravis (protocolSection.conditionsModule.conditions)
  • Lambert-eaton Myasthenic Syndrome (protocolSection.conditionsModule.conditions)
  • Primary Lateral Sclerosis (protocolSection.conditionsModule.conditions)
  • Spinal Muscular Atrophy (protocolSection.conditionsModule.conditions)
  • Charcot Marie Tooth Disease (CMT) (protocolSection.conditionsModule.conditions)
  • Fascioscapulohumeral Muscular Dystrophy (protocolSection.conditionsModule.conditions)
  • Inclusion Body Myositis (protocolSection.conditionsModule.conditions)
  • Mitochondrial Myopathy (protocolSection.conditionsModule.conditions)
  • Nemaline Myopathy (protocolSection.conditionsModule.conditions)
  • Centronuclear Myopathy (protocolSection.conditionsModule.conditions)
  • Postpolio Syndrome (protocolSection.conditionsModule.conditions)
  • Pompe Disease (Late-onset) (protocolSection.conditionsModule.conditions)
  • Chronic Inflammatory Demyelinating Polyneuropathy (protocolSection.conditionsModule.conditions)
  • Hereditary Spastic Paraplegia (protocolSection.conditionsModule.conditions)
  • Postural Orthostatic Tachycardia Syndrome (POTS) (protocolSection.conditionsModule.conditions)
  • Progressive Muscular Atrophy (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.